CC

Casdin Capital Portfolio holdings

AUM $1.61B
1-Year Est. Return 69.26%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+69.26%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.01B
AUM Growth
+$118M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
40
New
Increased
Reduced
Closed

Top Buys

1
+$93.8M
2
+$34.2M
3
+$11.8M
4
NTLA icon
Intellia Therapeutics
NTLA
+$7.82M
5
NGNE icon
Neurogene
NGNE
+$7.51M

Top Sells

1
+$87.8M
2
+$21.7M
3
+$9.53M
4
MXCT icon
MaxCyte
MXCT
+$5.9M
5
BPMC
Blueprint Medicines
BPMC
+$2.92M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$164M 16.16%
5,714,775
+3,904,775
2
$141M 13.95%
8,707,165
+927,165
3
$97.1M 9.57%
1,006,500
-3,830
4
$81.3M 8.02%
7,387,943
+464,369
5
$44.5M 4.39%
1,091,867
-166,299
6
$44.2M 4.36%
1,450,000
+271,925
7
$43.6M 4.3%
321,764
+296,064
8
$41.9M 4.14%
3,009,094
+54,384
9
$37.3M 3.68%
195,000
-5,000
10
$31.9M 3.14%
12,604,275
11
$31.1M 3.06%
420,000
-39,450
12
$30.1M 2.97%
326,378
-45,000
13
$28.6M 2.82%
1,577,108
14
$27.9M 2.75%
1,300,000
15
$20.9M 2.07%
1,033,811
16
$20.7M 2.04%
6,381,377
17
$14.4M 1.42%
528,000
-42,000
18
$13.5M 1.33%
2,360,129
19
$11.8M 1.16%
1,188,349
-119,000
20
$10.6M 1.05%
3,206,380
21
$10.6M 1.05%
1,175,750
-74,250
22
$10.2M 1%
+524,616
23
$10.2M 1%
1,035,859
24
$8.51M 0.84%
3,095,511
25
$7.67M 0.76%
2,050,000
1
2